Literature DB >> 33131207

Circular RNA profiling identifies circ102049 as a key regulator of colorectal liver metastasis.

Qiaoming Zhi1,2, Daiwei Wan2, Rui Ren3, Zhihua Xu2, Xiaobo Guo4, Ye Han2, Fei Liu5, Ye Xu1, Lei Qin2, Yilin Wang6.   

Abstract

Circular RNA (circRNA) plays an essential role in the development and progression of various cancers. However, the functions and mechanisms of circRNA in colorectal liver metastasis have not been fully elucidated. We performed circRNA microarray analysis to screen differentially expressed circRNA in the pathology of colorectal liver metastasis. Quantitative real-time PCR was used to detect the expression of hsa_circ_102049 (circ102049) in colorectal cancer (CRC) samples. CRC cells were transfected with circ102049 overexpression vector or small interfering (si)RNA to assess the effects of circ102049 in vitro. Bioinformatics analysis, fluorescence in situ hybridization, RNA immunoprecipitation, RNA pull-down and luciferase reporter assays were conducted to confirm the relationship of circ102049, miR-761, miR-192-3p and FRAS1. The mechanism by which circ102049 recruits and distributes DGCR8 protein in the cytoplasm was also investigated. We found that circ102049 was highly expressed in primary CRC tumors with liver metastasis and closely correlated with the prognosis of patients with CRC. Circ102049 significantly enhanced the adhesion, migration and invasion abilities of CRC cells, and promoted CRC progression via a micro (mi)R-761/miR-192-3p-FRAS1-dependent mechanism. Notably, due to the distribution of DGCR8 protein, circ102049 may also indirectly reduce the levels of mature miR-761 and miR-192-3p in the cytoplasm. In addition, the role of circ102049 in promoting colorectal liver metastasis was confirmed in vivo. Our findings provide new evidence that circ102049 may be a potential prognostic factor in CRC, and that the circ102049-miR-761/miR-192-3p-FRAS1 axis may be an anti-metastatic target for CRC patients.
© 2020 The Authors. Published by FEBS Press and John Wiley & Sons Ltd.

Entities:  

Keywords:  DGCR8; FRAS1; Hsa_circ_102049; colorectal liver metastasis; miR-192-3p; miR-761

Mesh:

Substances:

Year:  2020        PMID: 33131207      PMCID: PMC7858140          DOI: 10.1002/1878-0261.12840

Source DB:  PubMed          Journal:  Mol Oncol        ISSN: 1574-7891            Impact factor:   7.449


  44 in total

1.  Improved survival in metastatic colorectal cancer is associated with adoption of hepatic resection and improved chemotherapy.

Authors:  Scott Kopetz; George J Chang; Michael J Overman; Cathy Eng; Daniel J Sargent; David W Larson; Axel Grothey; Jean-Nicolas Vauthey; David M Nagorney; Robert R McWilliams
Journal:  J Clin Oncol       Date:  2009-05-26       Impact factor: 44.544

Review 2.  Dgcr8 knockout approaches to understand microRNA functions in vitro and in vivo.

Authors:  Wen-Ting Guo; Yangming Wang
Journal:  Cell Mol Life Sci       Date:  2019-01-29       Impact factor: 9.261

3.  FRAS1 knockdown reduces A549 cells migration and invasion through downregulation of FAK signaling.

Authors:  Qiong Zhan; Ruo-Fan Huang; Xiao-Hua Liang; Meng-Xi Ge; Jing-Wei Jiang; Hao Lin; Xin-Li Zhou
Journal:  Int J Clin Exp Med       Date:  2014-07-15

4.  Circ-0001313/miRNA-510-5p/AKT2 axis promotes the development and progression of colon cancer.

Authors:  Fang-Ling Tu; Xi-Qing Guo; Hai-Xia Wu; Zhi-Yun He; Fang Wang; Ai-Jun Sun; Xu-Dong Dai
Journal:  Am J Transl Res       Date:  2020-01-15       Impact factor: 4.060

Review 5.  Non-coding RNAs in GI cancers: from cancer hallmarks to clinical utility.

Authors:  Mihnea Paul Dragomir; Scott Kopetz; Jaffer A Ajani; George Adrian Calin
Journal:  Gut       Date:  2020-02-07       Impact factor: 23.059

6.  Survival after hepatic resection for metastatic colorectal cancer: trends in outcomes for 1,600 patients during two decades at a single institution.

Authors:  Michael G House; Hiromichi Ito; Mithat Gönen; Yuman Fong; Peter J Allen; Ronald P DeMatteo; Murray F Brennan; Leslie H Blumgart; William R Jarnagin; Michael I D'Angelica
Journal:  J Am Coll Surg       Date:  2010-05       Impact factor: 6.113

7.  NSD2 circular RNA promotes metastasis of colorectal cancer by targeting miR-199b-5p-mediated DDR1 and JAG1 signalling.

Authors:  Liang-Yan Chen; Zheng Zhi; Lian Wang; Yuan-Yuan Zhao; Min Deng; Yu-Hong Liu; Yan Qin; Meng-Meng Tian; Yao Liu; Tong Shen; Li-Na Sun; Jian-Ming Li
Journal:  J Pathol       Date:  2019-02-20       Impact factor: 7.996

Review 8.  Circular RNAs in hypertension: challenges and clinical promise.

Authors:  Mohamed Zaiou
Journal:  Hypertens Res       Date:  2019-06-25       Impact factor: 3.872

Review 9.  Translation and functional roles of circular RNAs in human cancer.

Authors:  Ming Lei; Guantao Zheng; Qianqian Ning; Junnian Zheng; Dong Dong
Journal:  Mol Cancer       Date:  2020-02-15       Impact factor: 27.401

10.  CircPTK2 (hsa_circ_0005273) as a novel therapeutic target for metastatic colorectal cancer.

Authors:  Hongbao Yang; Xiaobo Li; Qingtao Meng; Hao Sun; Shenshen Wu; Weiwei Hu; Guilai Liu; Xianjing Li; Yong Yang; Rui Chen
Journal:  Mol Cancer       Date:  2020-01-23       Impact factor: 27.401

View more
  14 in total

1.  Potential and functional prediction of six circular RNAs as diagnostic markers for colorectal cancer.

Authors:  Li Yuan Liu; Dan Jiang; Yuliang Qu; Hongxia Wang; Yanting Zhang; Shaoqi Yang; Xiaoliang Xie; Shan Wu; Haijin Zhou; Guangxian Xu
Journal:  PeerJ       Date:  2022-05-19       Impact factor: 3.061

Review 2.  Emerging Mechanisms and Treatment Progress on Liver Metastasis of Colorectal Cancer.

Authors:  Wubin Zheng; Fan Wu; Kai Fu; Guangshun Sun; Guoqiang Sun; Xiao Li; Wei Jiang; Hongyong Cao; Hanjin Wang; Weiwei Tang
Journal:  Onco Targets Ther       Date:  2021-05-06       Impact factor: 4.147

3.  CircIL4R activates the PI3K/AKT signaling pathway via the miR-761/TRIM29/PHLPP1 axis and promotes proliferation and metastasis in colorectal cancer.

Authors:  Tao Jiang; Hongyu Wang; Lianyu Liu; Hu Song; Yi Zhang; Jiaqi Wang; Lei Liu; Teng Xu; Ruizhi Fan; Yixin Xu; Shuai Wang; Linsen Shi; Li Zheng; Renhao Wang; Jun Song
Journal:  Mol Cancer       Date:  2021-12-18       Impact factor: 27.401

Review 4.  Circular RNA: A promising new star for the diagnosis and treatment of colorectal cancer.

Authors:  Shunhao Zhang; Jing Sun; Minqi Gu; Guihua Wang; Xudong Wang
Journal:  Cancer Med       Date:  2021-11-18       Impact factor: 4.452

5.  PRKAR2A-derived circular RNAs promote the malignant transformation of colitis and distinguish patients with colitis-associated colorectal cancer.

Authors:  Daiwei Wan; Sentai Wang; Zhihua Xu; Xinquan Zan; Fei Liu; Ye Han; Min Jiang; Airong Wu; Qiaoming Zhi
Journal:  Clin Transl Med       Date:  2022-02

Review 6.  Colorectal liver metastasis: molecular mechanism and interventional therapy.

Authors:  Hui Zhou; Zhongtao Liu; Yongxiang Wang; Xiaoyong Wen; Eric H Amador; Liqin Yuan; Xin Ran; Li Xiong; Yuping Ran; Wei Chen; Yu Wen
Journal:  Signal Transduct Target Ther       Date:  2022-03-04

7.  Circular RNA circRNA_0067934 promotes glioma development by modulating the microRNA miR-7/ Wnt/β-catenin axis.

Authors:  Yunlong Pei; Hongying Zhang; Kongye Lu; Xiaojia Tang; Jialing Li; Enpeng Zhang; Jun Zhang; Yujia Huang; Zhijie Yang; Zhenggang Lu; Yuping Li; Hengzhu Zhang; Lun Dong
Journal:  Bioengineered       Date:  2022-03       Impact factor: 3.269

Review 8.  Role of noncoding RNAs and untranslated regions in cancer: A review.

Authors:  Yiping Zhang; Meiwen Yang; Shulong Yang; Fenfang Hong
Journal:  Medicine (Baltimore)       Date:  2022-08-19       Impact factor: 1.817

Review 9.  Critical Roles of Circular RNA in Tumor Metastasis via Acting as a Sponge of miRNA/isomiR.

Authors:  Li Guo; Lin Jia; Lulu Luo; Xinru Xu; Yangyang Xiang; Yujie Ren; Dekang Ren; Lulu Shen; Tingming Liang
Journal:  Int J Mol Sci       Date:  2022-06-24       Impact factor: 6.208

10.  CircKPNB1 mediates a positive feedback loop and promotes the malignant phenotypes of GSCs via TNF-α/NF-κB signaling.

Authors:  Yang Jiang; Junshuang Zhao; Yingliang Liu; Juntao Hu; Liang Gao; Hui Wang; Daming Cui
Journal:  Cell Death Dis       Date:  2022-08-09       Impact factor: 9.685

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.